Disclosure 0001193125-26-383625-1

SEC FORM 4

$115,637.91

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 10,366 shares at $11.1555 per share.

Reporting Person Horan Christopher · Officer Title Chief Tech Operations Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383625 · filed 2026-09-04 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Artiva Biotherapeutics, Inc. (ARTV)." Disclosed 2026-09-04. https://desqlong.com/cards/0001193125-26-383625-1 (retrieved 2026-09-26).